Revive Biotechnology
UEI: GR6BLT49FMG4
• CAGE: 87ZC9
Overview
Awardee Type
Parent
Company Description
Mission Blinding retinal disease due to tissue hypoxia remains a significant unmet need impacting just under 1 million patients per year stemming from conditions including artery and vein occlusions to diabetic retinopathy. ReVive Biotechnology, Inc. is dedicated to developing nano-carriers for the effective treatment of hypoxic conditions. Our mission is to improve visual outcomes and […]
Name
Revive Biotechnology
Website
Headquarters
Naples, FL
United States
United States
Most Recent Award
Aug. 1, 2023
Calculating
Federal grant recipient
REVIVE BIOTECHNOLOGY INC
(UEI GR6BLT49FMG4, CAGE 87ZC9)
is headquartered in Naples FL.
Its primary registered NAICS is 541714 Research and Development in Biotechnology (except Nanobiotechnology).
The corporation
was founded in September 2018 and
federally registered in
December 2018.
Federal Award Analysis
Revive Biotechnology federal award history
$-
Contracts
$-
Subcontracts
$-
Grants
$-
Subgrants
$-
Total
No Results
Calculating
Calculating
No Results
Calculating
Calculating
No Results
Calculating
Calculating
| Year | Contracts | Subcontracts | Grants | Subgrants |
|---|
No Results
Calculating
Calculating
No Results
Calculating
Calculating
Federal Registration and Certifications
Legal Name
REVIVE BIOTECHNOLOGY INC
UEI
GR6BLT49FMG4
CAGE Code
87ZC9
SBA Certifications
None
Self Certifications
Self-Certified Small Disadvantaged Business
Entity Structure
Corporate Entity (Not Tax Exempt)
Purpose of Registration
Federal Contracts and Assistance
Date Founded
Sept. 15, 2018
Initial Registration
Dec. 9, 2018
Last Registration
March 18, 2025
Registration Activation
March 18, 2025
Registration Expiration
March 14, 2026
Fiscal Year End
December 31
Reported Entity Types
For Profit Organization
State of Incorporation
DE
Country of Incorporation
USA
Employees
<500
Accepts Credit Cards
No